Calliditas Therapeutics AB News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.06.24	These Biotech Stocks Hit New Highs, Did You Reap The Rewards? (RTTNews)
28.05.24	Asahi Kasei To Acquire Calliditas - Quick Facts (RTTNews)
06.05.24	Calliditas Announces Positive Data From Proof-of-concept Phase 2 Trial With Setanaxib (RTTNews)
08.04.24	Calliditas Gets Notice Of Allowance For U.S. Patent Application Covering Setanaxib To Treat Cancer (RTTNews)
20.03.24	Everest Medicines : Singapore Approves Nefegan For Treatment Of Primary IgA Nephropathy In Adult (RTTNews)
12.03.24	Calliditas Therapeutics Receives Seven More Years Of Market Exclusivity For Nefecon In U.S. (RTTNews)
21.12.23	Calliditas Therapeutics' Kidney Disease Drug Gets FDA Approval; Stock Surges (RTTNews)
30.11.23	Biotech Stocks Facing FDA Decision In December 2023 (RTTNews)
24.11.23	Everest Medicines Reports Nefecon's Approval In China; Triggers Milestone Payment To Calliditas (RTTNews)
27.10.23	Calliditas Therapeutics: Everest Gets Approval For Nefecon In Macau - Quick Facts (RTTNews)
21.08.23	Calliditas Receives FDA Priority Review For Full Approval Of Nefecon For IgA Nephropathy Treatment (RTTNews)
21.08.23	Everest Medicines Announces Partner Calliditas Therapeutics Receives FDA Priority Review for Full Approval of Nefecon® for the Treatment of IgA Nephropathy (PR Newswire)
18.08.23	Calliditas: SNDA For TARPEYO Granted Priority Review By FDA (RTTNews)
18.08.23	Everest Medicines' Partner Calliditas Therapeutics Announces Full Results From NefIgArd Phase 3 Trial published in The Lancet (PR Newswire)
21.06.23	Calliditas Files SNDA Seeking Full Approval Of TARPEYO - Quick Facts (RTTNews)
23.05.23	Pre-market Movers: BIOC, MVLA, COYA, PACW, OMH… (RTTNews)
16.05.23	Pre-market Movers: GDC, ELOX, VOXX, HZNP, CALT… (RTTNews)
13.03.23	Pre-market Movers: PRVB, FRC, PACW, WAL, CAL… (RTTNews)
13.03.23	Calliditas : Phase 3 Trial Of Nefecon In IgA Nephropathy Meets Primary Endpoint (RTTNews)
23.02.23	Pre-market Movers: LUNR, GSM, CALT, ENVX, HRTX… (RTTNews)
13.12.22	Calliditas To Work With Viatris To Bring Nefecon To Japanese Patients (RTTNews)
21.10.22	Pre-market Movers: IMUX, ARC, SNAP, VRE, JAN… (RTTNews)
18.07.22	Everest Medicines Announces European Commission Grants Approval of Kinpeygo® for Adults with Primary IgA Nephropathy to our Partner Calliditas Therapeutics (PR Newswire)
19.05.22	Calliditas: CHMP Adopts Positive Opinion On Conditional Marketing Authorisation For Kinpeygo (RTTNews)
14.03.22	Everest Medicines Enters into Agreement with Calliditas Therapeutics, Expanding Territory License to Develop and Commercialize NEFECON in South Korea (PR Newswire)
20.12.21	Pre-market Movers: SOPA, VRS, ITCI, IMMX, SPRB… (RTTNews)
16.12.21	Pre-market Movers: CALT, SABS, IRNT, CTK, VALN… (RTTNews)
16.12.21	FDA Grants Calliditas Accelerated Approval Of Tarpeyo To Reduce Proteinuria In IgA Nephropathy (RTTNews)
29.11.21	Biotech Stocks Facing FDA Decision In December 2021 (RTTNews)
15.09.21	Pre-market Movers: NXTD, KAVL, SONM, MITC, BTCS… (RTTNews)
30.08.21	Biotech Stocks Facing FDA Decision In September 2021 (RTTNews)
19.08.21	Calliditas Therapeutics: Interim Report Q2, 2021 (PR Newswire)
19.08.21	Calliditas Therapeutics: Interim Report Q2, 2021 (PR Newswire)
17.08.21	Pre-market Movers: CRDL, LMFA, FBRX, QLGN, SMFR… (RTTNews)
13.08.21	Calliditas Therapeutics has resolved on a directed share issue in the amount of 2.4 million shares, raising proceeds of approximately SEK 324 million (PR Newswire)
13.08.21	Calliditas Therapeutics has resolved on a directed share issue in the amount of 2.4 million shares, raising proceeds of approximately SEK 324 million (PR Newswire)
12.08.21	Calliditas Therapeutics intends to carry out a directed share issue (PR Newswire)
09.08.21	Calliditas Receives FDA Fast Track Designation for setanaxib in PBC (PR Newswire)
09.08.21	Calliditas Receives FDA Fast Track Designation for setanaxib in PBC (PR Newswire)
21.07.21	Calliditas Therapeutics and STADA partner to register and commercialize specialty therapy for IgA Nephropathy in Europe (PR Newswire)
15.07.21	Calliditas secures $75 million term loan facility (PR Newswire)
15.07.21	Calliditas secures $75 million term loan facility (PR Newswire)
01.12.20	IPO Lockup Expiration Alert: Calliditas Therapeutics (CALT) (RTTNews)
12.11.20	Pre-market Movers In Healthcare Sector: IMAC, BNGO, LMNL, FPRX, EQ… (RTTNews)
10.11.20	ARNA Falls Short Of ADVICE, PFE's COVID-19 Vaccine Shows 90% Efficacy, SUPN Hit By Double Whammy (RTTNews)
09.11.20	Stock Alert: Calliditas Therapeutics Jumps 30% On Positive Results From Kidney Disease Drug Trial (RTTNews)
19.10.20	Calliditas Therapeutics: On The Watch For Nefigard Data (RTTNews)
01.09.20	Pre-market Movers In Healthcare Sector: APM, TTOO, BCRX, ZSAN, BNTX... (RTTNews)
05.06.20	Calliditas Therapeutics Prices IPO At $19.50/ADS (RTTNews)
04.06.20	What's On The Healthcare IPO Calendar Friday? (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Calliditas Therapeutics AB (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten